ISPOR - HPR110 ESG in Pharma Procurement, Not More Than Wishful Thinking? A Quantitative View on Award Criteria in Tenders in the EU5 From 2011 to 2020

HPR110 ESG in Pharma Procurement, Not More Than Wishful Thinking? A Quantitative View on Award Criteria in Tenders in the EU5 From 2011 to 2020

Abstract

Authors

C Genane S Trenti

Full Text Cite This Article

Back to Volume 25, Supplemental Issue 12S

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now